New chimeric advanced Drug Delivery nano Systems (chi-aDDnSs) as doxorubicin carriers

International Journal of Pharmaceutics

Volumn 402, Issue 1-2, 2010, Pages 231-237

  Gardikis, Konstantinos ^a   Tsimplouli, Chrisiida ^c   Dimas, Konstantinos ^c   Micha Screttas, Maria ^b   Demetzos, Costas ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^c INSTITUTE OF BIOLOGY   (Greece)

Author keywords

Chimeric advanced Drug Delivery nano System (chi aDDnS); Dendrimer; In vitro cytotoxicity; Liposome; Myocet

Indexed keywords

DOXORUBICIN; LIPOSOME; NANOCARRIER;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL STRAIN MB231; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; FREEZE DRYING; HUMAN; HUMAN CELL; IN VITRO STUDY; LC 50; NANOTECHNOLOGY; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

ANTIBIOTICS, ANTINEOPLASTIC; BREAST NEOPLASMS; CELL LINE, TUMOR; DELAYED-ACTION PREPARATIONS; DENDRIMERS; DOXORUBICIN; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; LIPOSOMES; NANOPARTICLES; NANOTECHNOLOGY;

EID: 78349312939     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.10.007     Document Type: Article

References (32)

1. Abraham S.A., Waterhouse D.N., Mayer L.D., Cullis P.R., Madden T.D., Bally M.B. The liposomal formulation of doxorubicin. Methods in Enzymology 2005, 71-97. Academic Press. D. Nejat (Ed.).
2. Demetzos C. Drug delivery nanosystems and their classification based on their dynamic variability. 2nd International Symposium on Biological Applications of Dendrimers, June 23-26 2010.
3. Demetzos C. Advances in drug delivery systems (DDSs). International Congress on New Delivery Systems, Biosimilars, Bioequivalence-Biowaivers-Biotechnology Products, July 2-3 2010.
4. Fritze A., Hens F., Kimpfler A., Schubert R., Peschka-Suss R. Remote loading of doxorubicin into liposomes driven by a transmembrane phosphate gradient. Biochim. Biophys. Acta: Biomembranes 2006, 1758:1633-1640.
5. Gardikis K., Dimas K., Georgopoulos A., Kaditi E., Pispas S., Demetzos C. Beta-lactam functionalized poly(isoprene-b-ethylene oxide) amphiphilic block copolymer micelles as a New Nanocarrier System for Curcumin. Curr. Nanosci. 2010, 6:277-284.
6. Gardikis K., Hatziantoniou S., Bucos M., Fessas D., Signorelli M., Felekis T., Zervou M., Screttas C.G.S Steele##B.R., Ionov M., et al. New drug delivery nanosystem combining liposomal and dendrimeric technology (liposomal locked-in Dendrimers) for cancer therapy. J. Pharm. Sci. 2010, 99:3561-3571.
7. Gardikis K., Hatziantoniou S., Signorelli M., Pusceddu M., Micha-Screttas M., Schiraldi A., Demetzos C., Fessas D. Thermodynamic and structural characterization of liposomal-locked in-dendrimers as drug carriers. Colloids Surf. B: Biointerfaces. 2010, 81:11-19.
8. Gardikis K., Hatziantoniou S., Viras K., Wagner M., Demetzos C. A DSC and Raman spectroscopy study on the effect of PAMAM dendrimer on DPPC model lipid membranes. Int. J. Pharm. 2006, 318:118-123.
9. Gillies E.R., Frechet J.M.J. Designing macromolecules for therapeutic applications: polyester dendrimer-poly(ethylene oxide) " bow-tie" hybrids with tunable molecular weight and architecture. J. Am. Chem. Soc. 2002, 124:14137-14146.
10. Gillies E.R., Frechet J.M.J. Dendrimers and dendritic polymers in drug delivery. Drug Discov. Today 2005, 10:35-43.
11. Hatziantoniou S., Demetzos C. Qualitative and quantitative one-step analysis of lipids and encapsulated bioactive molecules in liposome preparations by HPTLC/FID (IATROSCAN). J. Liposome Res. 2006, 16:321-330.
12. Hupfeld S., Moen H.H., Ausbacher D., Haas H., Brandl M. Liposome fractionation and size analysis by asymmetrical flow field-flow fractionation/multi-angle light scattering: influence of ionic strength and osmotic pressure of the carrier liquid. Chem. Phys. Lipids. 2010, 163:141-147.
13. Ke W.L., Zhao Y.S., Huang R.Q., Jiang C., Pei Y.Y. Enhanced oral bioavailability of doxorubicin in a dendrimer drug delivery system. J. Pharm. Sci. 2008, 97:2208-2216.
14. Khopade A.J., Caruso F., Tripathi P., Nagaich S., Jain N.K. Effect of dendrimer on entrapment and release of bioactive from liposomes. Int. J. Pharm. 2002, 232:157-162.
15. Klajnert B., Epand R.M. PAMAM dendrimers and model membranes: differential scanning calorimetry studies. Int. J. Pharm. 2005, 305:154-166.
16. Lai P.S., Lou P.J., Peng C.L., Pai C.L., Yen W.N., Huang M.Y., Young T.H., Shieh M.J. Doxorubicin delivery by polyamidoamine dendrimer conjugation and photochemical internalization for cancer therapy. J. Control. Release 2007, 122:39-46.
17. Ma P., Dong X.W., Swadley C.L., Gupte A., Leggas M., Ledebur H.C., Mumper R.J. Development of idarubicin and doxorubicin solid lipid nanoparticles to overcome pgp-mediated multiple drug resistance in leukemia. J. Biomed. Nanotechnol. 2009, 5:151-161.
18. Maeda H. The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv. Enzyme Regul. 2001, 41:189-207.
19. Maeda H., Bharate G.Y., Daruwalla J. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. Eur. J. Pharm. Biopharm. 2009, 71:409-419.
20. Maeda H., Wu J., Sawa T., Matsumura Y., Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Control. Release 2000, 65:271-284.
21. Martí A., Armengol X., Estelrich J., Hernández-Borrell J. Encapsulation of doxorubicin in neutral liposomes by passive methods: evidence of drug-lipid interaction at neutral pH. J. Microencapsul. 1991, 9:191-200.
22. Papagiannaros A., Dimas K., Papaioannou G.T., Demetzos C. Doxorubicin-PAMAM dendrimer complex attached to liposomes: cytotoxic studies against human cancer cell lines. Int. J. Pharm. 2005, 302:29-38.
23. Papagiannaros A., Hatziantoniou S., Dimas K., Papaioannou G.T., Demetzos C. A liposomal formulation of doxorubicin, composed of hexadecylphosphocholine (HePC): physicochemical characterization and cytotoxic activity against human cancer cell lines. Biomed. Pharmacother. 2006, 60:36-42.
24. Sun H.L., Guo B.N., Cheng R., Meng F.H., Liu H.Y., Zhong Z.Y. Biodegradable micelles with sheddable poly(ethylene glycol) shells for triggered intracellular release of doxorubicin. Biomaterials 2009, 30:6358-6366.
25. Szoka F., Papahadjopoulos D. Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc. Natl. Acad. Sci. U.S.A. 1978, 75:4194-4198.
26. Tekade R.K., Kumar P.V., Jain N.K. Dendrimers in oncology: an expanding horizon. Chem. Rev. 2009, 109:49-87.
27. Tomalia D.A. Birth of a new macromolecular architecture: dendrimers as quantized building blocks for nanoscale synthetic polymer chemistry. Prog. Polym. Sci. 2005, 30:294-324.
28. Tomalia D.A., Fréchet J.M.J. Discovery of dendrimers and dendritic polymers: a brief historical perspective. J. Polym. Sci. Part A: Polym. Chem. 2002, 40:2719-2728.
29. Tomalia D.A., Naylor A.M., Goddard W.A. Starburst dendrimers: molecular-level control of size, shape, surface chemistry, topology, and flexibility from atoms to macroscopic matter. Angew. Chem. Int. Ed. Eng. 1990, 29:138-175.
30. Van Bommel E.M.G., Crommelin D.J.A. Stability of doxorubicin-liposomes on storage: as an aqueous dispersion, frozen or freeze-dried. Int. J. Pharm. 1984, 22:299-310.
31. vanWinden E.C.A., Crommelin D.J.A. Long term stability of freeze-dried, lyoprotected doxorubicin liposomes. Eur. J. Pharm. Biopharm. 1997, 43:295-307.
32. Wang N., Wang T., Li T.F., Deng Y.J. Modulation of the physicochemical state of interior agents to prepare controlled release liposomes. Colloids Surf. B: Biointerfaces 2009, 69:232-238.